During the past decade, District Oncology Dispensary; Department for Oncology and Dermatology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "District Oncology Dispensary; Department for Oncology and Dermatology" are "Basal Cell Carcinoma" (1 trials) and "Malignant Melanoma" (1 trials). Many other conditions were trialed in "District Oncology Dispensary; Department for Oncology and Dermatology" in a lesser frequency.

Most popular intervention types in "District Oncology Dispensary; Department for Oncology and Dermatology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Vemurafenib" (1 trials) and "vismodegib" (1 trials). Other intervention names were less common.

The vast majority of trials in "District Oncology Dispensary; Department for Oncology and Dermatology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "District Oncology Dispensary; Department for Oncology and Dermatology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in District Oncology Dispensary; Department for Oncology and Dermatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in District Oncology Dispensary; Department for Oncology and Dermatology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".